Table 1 Demographic and clinical characteristics in patients who underwent colonoscopy
From: The impact of face shields on the quality of gastrointestinal endoscopy during the COVID-19 pandemic
|  | Face shield (n = 679) | Non-face shield (n = 680) | P value |
|---|---|---|---|
Age | 61.56 ± 11.32 | 62.68 ± 11.07 | 0.067 |
Gender | 0.803 | ||
 Male | 381 | 377 |  |
 Female | 298 | 303 |  |
Bowel preparation | 0.565 | ||
 BBPS 8,9 | 377 | 367 |  |
 BBPS 6,7 | 302 | 313 |  |
Sedation | 0.705 | ||
 Yes | 666 | 665 |  |
 No | 13 | 15 |  |
Antiplatelet or anticoagulation use | 0.937 | ||
 Yes | 71 | 72 |  |
 No | 608 | 608 |  |
Examination of day | 0.487 | ||
 Morning | 183 | 172 |  |
 Afternoon | 496 | 508 |  |
Reason of examination | 0.461 | ||
 Screening | 516 | 505 |  |
 Surveillance | 163 | 175 |  |
Type of colonocope | 0.846 | ||
 CV-290 | 300 | 304 |  |
 EPK-i7010 | 379 | 376 |  |
Endoscopist’s experience | 0.683 | ||
 Experienced | 317 | 325 |  |
 Trainee | 362 | 355 |  |